Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Advair - CRP study.

Trial Profile

Advair - CRP study.

Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Fluticasone propionate; Salmeterol/fluticasone propionate
  • Indications Chronic obstructive pulmonary disease
  • Focus Pharmacodynamics
  • Acronyms ABC
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 01 Jun 2008 Results have been reported in the American Journal of Respiratory Critical Care Medicine.
    • 01 Jun 2008 Status changed from recruiting to completed, based on published results.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top